GDP
XBI icon

Great Diamond Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Great Diamond Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
+19,315
New +$2.61M 0.53% 54
2020
Q1 		– Sell
-422
Closed -$40K – 610
2019
Q4 		$40K Buy
+422
New +$36.5K 0.02% 337

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Great Diamond Partners's XBI Position: Q2 2026 in Review

Great Diamond Partners opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 19,315 shares worth $3.06M. The stake represents 0.53% of the portfolio and ranks #54 among its holdings. This is a return to the name: Great Diamond Partners previously reported a position in XBI as recently as Q4 2019.

Great Diamond Partners first reported a position in XBI in Q4 2019 and has held it in 2 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Great Diamond Partners held 19,315 shares of State Street SPDR S&P Biotech ETF worth $3.06M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Great Diamond Partners position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.53% of Great Diamond Partners's portfolio in Q2 2026, its #54 holding.
  • Great Diamond Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 2 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Great Diamond Partners's 13F filing for Q2 2026, filed 17 Jul 2026.